equityflowunderstand the flow and follow it
EquityFlow › Companies › Rhelixa

Rhelixa

Biotech · Tokyo, JP

Epigenetic-clock biological-age assessment and anti-aging (Epiclock)

Funding history

DateRoundAmount
Aug 2024Series B
Rhelixa, an epigenetics anti-aging startup, raised 490M JPY in Series B from Daiwa Corporate Investment, the KIRIN Health Innovation Fund and Leave a Nest Capital (incl. loans), taking cumulative funding to 1.28B JPY.
$3.2M

Investors

Tap an investor to see what else they have backed.

Daiwa Corporate InvestmentKirin Health Innovation FundLeave a Nest Capital

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in JP

PayPayRapidusMWAracanSmart CraftHerLifeLabTokenzDubGuildDJ InsightSnack TechnologiesNekonomeLinQ

Other companies at Series B stage

0x Labs11x.ai1K Kirana1X Technologies1plusX3Commas3SC4baseCare4screen8fig9finACALL
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.